South Korea Food and Drug Administration Investigates E-Cigarette Products

Sep.06.2024
South Korea Food and Drug Administration Investigates E-Cigarette Products
Korean authorities investigate e-cigarette liquids containing nicotine-like substances despite being labeled as nicotine-free.

According to N.News on September 6th, the South Korean Food and Drug Safety Ministry has decided to launch an on-site investigation after finding a substance similar to nicotine in nicotine-free e-cigarette liquid.


The organization stated today (6th) that some liquid inhalation products, including nicotine-like substances, are being marketed online under the guise of being "nicotine-free" products. Nicotine-like substances are chemicals with structures similar to nicotine, with methyl nicotine being a representative example.


The organization issued a warning stating that


Due to the lack of verified safety, it is advised not to inhale these products.


Currently, in products similar to cigarettes that are inhaled, those without nicotine and used to improve smoking habits are designated as over-the-counter drugs. As of now, the only nicotine-free product approved by the South Korean Ministry of Food and Drug Safety is "End Puff" domestically.


Prior to this, KBS reported in June on products containing substances similar to nicotine. These products do not fall under the category of non-prescription nicotine products and do not comply with the Tobacco Business Act, and are being sold online.


The South Korean Ministry of Food and Drug Safety stated,


From January to August of this year, we have inspected online products that falsely or exaggeratingly promote themselves as aids to quitting smoking, and have blocked a total of 448 posts. We will continue to inspect advertisements or labels that may be mistaken for non-prescription drugs.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PLONQ Interpreted the Domestic Market at the 2Firsts Forum: Multiple Categories Advancing Together, Channel Reconstruction, and Regulatory Direction Unclear
PLONQ Interpreted the Domestic Market at the 2Firsts Forum: Multiple Categories Advancing Together, Channel Reconstruction, and Regulatory Direction Unclear
At the 2Firsts Global NGP Rethink Forum, PLONQ's Asia regional director, Kenneth Tam provided an in-depth analysis of the nicotine market landscape in Russia. He pointed out that the trend of coexistence of multiple product categories is accelerating, the structure of retail channels is being reconfigured, and regulatory policies are fraught with uncertainties. This demonstrated PLONQ's deep cultivation of the local market and its global strategic vision.
Jul.31 by 2FIRSTS.ai
Singapore MOE: 3,100 Students Caught Vaping Annually; Harsher Punishments and Testing to Begin in September
Singapore MOE: 3,100 Students Caught Vaping Annually; Harsher Punishments and Testing to Begin in September
Between 2022 and 2024, Singapore recorded an average of 3,100 student vaping cases each year, including about 800 annually in tertiary institutions, far above the fewer than 50 cases reported before 2020. Since March, ~260 schools have been issued nicotine testing kits, and from September 1, schools will impose stricter disciplinary measures. Concurrently, authorities will intensify enforcement across public spaces, the military and borders, with Kpods (etomidate-containing e-cigs) to be treated
Aug.29 by 2FIRSTS.ai
EVE Energy Plans ¥8.65 Billion Investment in Malaysia for Energy Storage Base, Applies for Hong Kong IPO
EVE Energy Plans ¥8.65 Billion Investment in Malaysia for Energy Storage Base, Applies for Hong Kong IPO
Eve Energy plans $8.65 billion investment in Malaysia for energy storage battery base, submits H-share IPO application.
Jul.02 by 2FIRSTS.ai
Reuters: BAT to Launch Synthetic Nicotine Vape Vuse One in U.S., Hitting Shelves in Three States from Late September
Reuters: BAT to Launch Synthetic Nicotine Vape Vuse One in U.S., Hitting Shelves in Three States from Late September
British American Tobacco (BAT) plans to pilot sales of its disposable synthetic nicotine vape, Vuse One, in the United States, with launches expected in South Carolina, Florida, and Georgia in late September. The product has not yet received approval from the U.S. Food and Drug Administration (FDA). According to Reuters, this move marks a major shift in BAT’s stance after years of opposing the sale of unauthorized vapes. The company said the product will be distributed through major national ret
Aug.21 by 2FIRSTS.ai
2Firsts Interview | Sneak Peek: Westfallenhallen’s Sabine Loos Reveals What Visitors Can Expect at InterTabac 2025
2Firsts Interview | Sneak Peek: Westfallenhallen’s Sabine Loos Reveals What Visitors Can Expect at InterTabac 2025
As an official media partner of InterTabac, 2Firsts spoke exclusively with Sabine Loos, Managing Director of Westfalenhallen Unternehmensgruppe, to preview the 45th edition of the event. This year’s InterTabac and InterSupply will feature 11 halls, over 800 exhibitors, dozens of forums, and major product debuts. The interview explores trends in NGPs, oral nicotine, hybrid formats, and global regulatory topics—offering a comprehensive look into innovation and industry dialogue.
Aug.06
Philippines NBI Cracks Down on Illegal Vapes in July, Announces Third Enforcement Case
Philippines NBI Cracks Down on Illegal Vapes in July, Announces Third Enforcement Case
The Philippines’ National Bureau of Investigation (NBI) has intensified its crackdown on the illegal vape market, launching a series of large-scale sting operations. Since July, the NBI has dismantled illegal e-cigarette distribution networks in several regions, arrested multiple suspects, and seized unregistered vape products worth millions of pesos.
Jul.08